<?xml version="1.0" encoding="UTF-8"?>
<p>Safety and efficacy trials conducted on captive harbor and Hawaiian monk seals demonstrated no adverse reactions and no shedding of canary pox [
 <xref rid="B152-viruses-06-05093" ref-type="bibr">152</xref>]. All subjects developed positive CDV (though not PDV) titers after receiving a booster approximately one month following initial vaccination. The vaccine has also proven to be a safe and effective prophylactic treatment for captive southern sea otters (
 <italic>E. lutra nereis</italic>) [
 <xref rid="B153-viruses-06-05093" ref-type="bibr">153</xref>].
</p>
